Skin Diseases, Genetic
7 clinical trials · Condition
◉ Watch Skin Diseases, Genetic
| Record | Firm | Date |
|---|---|---|
| A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis (NCT04760314) | Eli Lilly and Company | 2021-03-10 |
| Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy (NCT03720470) | Pfizer | 2018-10-29 |
| Effect of Benralizumab in Atopic Dermatitis (NCT03563066) | McMaster University | 2018-09-04 |
| Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects (NCT03627767) | Pfizer | 2018-06-11 |
| A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists (NCT02916888) | Yale University | 2016-09-01 |
| Effects of Treatments on Atopic Dermatitis (NCT01631617) | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | 2012-09-18 |
Track Skin Diseases, Genetic automatically
Every clearance here is in the API, with alerts when new ones post.